BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1387814)

  • 1. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis.
    Miyauchi J; Ito Y; Kawano T; Tsunematsu Y; Shimizu K
    Blood; 1992 Sep; 80(6):1521-7. PubMed ID: 1387814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse hepatic fibrosis with transient myeloproliferative disorders in Down syndrome.
    Hongeng S; Pakakasama S; Hathirat P; Phuapradid P; Worapongpaiboon S
    J Pediatr Hematol Oncol; 2000; 22(6):543-4. PubMed ID: 11132225
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
    Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
    Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
    Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
    Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
    Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
    Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
    Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
    Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis.
    Schwab M; Niemeyer C; Schwarzer U
    Med Pediatr Oncol; 1998 Sep; 31(3):159-65. PubMed ID: 9722898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker.
    McElwaine S; Mulligan C; Groet J; Spinelli M; Rinaldi A; Denyer G; Mensah A; Cavani S; Baldo C; Dagna-Bricarelli F; Hann I; Basso G; Cotter FE; Nizetic D
    Br J Haematol; 2004 Jun; 125(6):729-42. PubMed ID: 15180862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
    Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
    Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
    Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
    Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome.
    Yagihashi N; Watanabe K; Yagihashi S
    J Clin Pathol; 1995 Oct; 48(10):973-5. PubMed ID: 8537505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
    Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
    Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome].
    Creutzig U; Ritter J; Vormoor J; Eschenbach C; Dickerhoff R; Burdach S; Scheel-Walter HG; Kühl J; Schellong G
    Klin Padiatr; 1990; 202(4):253-7. PubMed ID: 2144325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
    Sartori PC; Darbyshire PJ
    Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse liver fibrosis associated with transient myeloproliferative disorder in Down's syndrome].
    Villamor Zambrano E; Alonso Ortiz T; Arizcun Pineda J; Moro Serrano M
    An Esp Pediatr; 1997 Jul; 47(1):69-70. PubMed ID: 9382333
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
    Kurahashi H; Hara J; Yumura-Yagi K; Murayama N; Inoue M; Ishihara S; Tawa A; Okada S; Kawa-Ha K
    Blood; 1991 Mar; 77(6):1161-3. PubMed ID: 1672097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.